Compare Davita Inc (DVA) vs Direxion NASDAQ 100 Equal Weighted Index Shares (QQQE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.19 (market cap $1.45B). The key difference: Davita Inc is far larger — about 7.8× Direxion NASDAQ 100 Equal Weighted Index Shares's market cap, and Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Direxion NASDAQ 100 Equal Weighted Index Shares for 47 Days on average.
| DVA | QQQE | |
|---|---|---|
Market Cap | $11.29B | $1.45B |
Volume | 582,204 | 323,568 |
Sector | Health | Broad Market / Factor |
52-Week High | $240.96 | $124.69 |
52-Week Low | $103.87 | $96.06 |
Typical Hold Time | 113 Days | 47 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
QQQE trades at $121.89, down 0.89% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF provides equal-weighted exposure to NASDAQ-100 large-cap growth stocks, reducing technology concentration compared to market-cap weighted alternatives. Recent analysis highlights QQQE's tactical appeal for diversification within tech-heavy indices.
The equal-weight methodology offers fundamental diversification benefits, though specific financial ratios are unavailable for the ETF structure. Market sentiment appears constructive with technical strength, but investors face typical ETF risks including market volatility and sector concentration despite the equal-weight approach.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Direxion NASDAQ 100 Equal Weighted Index Shares
QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →
